X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (758) 758
humans (665) 665
male (360) 360
female (328) 328
middle aged (263) 263
aged (196) 196
adult (184) 184
continuous intravenous heparin (183) 183
hematology (152) 152
treatment outcome (140) 140
urology & nephrology (131) 131
animals (110) 110
continuous venovenous hemofiltration (109) 109
abridged index medicus (105) 105
hemodialysis (100) 100
molecular-weight heparin (98) 98
heparin (97) 97
surgery (96) 96
anticoagulants - therapeutic use (95) 95
deep-vein thrombosis (94) 94
care and treatment (93) 93
acute kidney injury - therapy (83) 83
risk factors (83) 83
renal replacement therapy (81) 81
cardiac & cardiovascular systems (80) 80
therapy (79) 79
continuous renal replacement therapy (78) 78
pharmacology & pharmacy (78) 78
prospective studies (78) 78
peripheral vascular disease (77) 77
hemofiltration (76) 76
medicine, general & internal (76) 76
initial treatment (75) 75
critically-ill patients (74) 74
infusions, intravenous (74) 74
critical care medicine (73) 73
pediatrics (73) 73
medicine & public health (72) 72
retrospective studies (71) 71
venous thrombosis (71) 71
failure (70) 70
heparin - therapeutic use (70) 70
time factors (70) 70
subcutaneous heparin (68) 68
child (64) 64
anticoagulants - administration & dosage (63) 63
unfractionated heparin (62) 62
heparin - administration & dosage (60) 60
respiratory system (59) 59
aged, 80 and over (58) 58
anesthesiology (58) 58
adolescent (57) 57
transplantation (57) 57
acute kidney injury (56) 56
continuous-infusion (56) 56
partial thromboplastin time (56) 56
pharmacokinetics (56) 56
health aspects (55) 55
pulmonary-embolism (55) 55
continuous infusion (54) 54
anticoagulants - adverse effects (51) 51
anticoagulation (51) 51
children (51) 51
management (51) 51
mortality (50) 50
anticoagulants (49) 49
dialysis (48) 48
acute renal failure (46) 46
blood (45) 45
research (45) 45
analysis (44) 44
hemodiafiltration (44) 44
heparin, low-molecular-weight - therapeutic use (44) 44
long-term treatment (44) 44
child, preschool (43) 43
drug therapy (43) 43
hemofiltration - methods (43) 43
heparin - adverse effects (42) 42
nephrology (42) 42
recurrence (42) 42
renal replacement therapy - methods (42) 42
diagnosis (41) 41
randomized trial (41) 41
drug administration schedule (40) 40
peritoneal dialysis (40) 40
complications and side effects (39) 39
thromboembolism (39) 39
sepsis (38) 38
critical illness (37) 37
venous thrombosis - drug therapy (37) 37
infant (36) 36
intensive care units (36) 36
proximal-vein thrombosis (36) 36
thrombosis (36) 36
dose-response relationship, drug (35) 35
follow-up studies (35) 35
renal dialysis (35) 35
thromboembolism - drug therapy (35) 35
heparin, low-molecular-weight - administration & dosage (34) 34
infant, newborn (34) 34
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
West Park Healthcare Centre - Hospital Department (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 03/2012, Volume 10, Issue 3, pp. 368 - 374
Background:  Unfractionated heparin (UFH) is a widely used anticoagulant. Current American College of Chest Physicians guidelines for infants extrapolated from... 
heparin | infants | pediatrics | Pediatrics | Infants | Heparin | VENOUS THROMBOSIS | PARTIAL THROMBOPLASTIN TIME | CHILDREN | CONTINUOUS INTRAVENOUS HEPARIN | THERAPY | HUMAN COAGULATION SYSTEM | MOLECULAR-WEIGHT HEPARIN | PEDIATRIC-PATIENTS | SUBCUTANEOUS HEPARIN | PERIPHERAL VASCULAR DISEASE | HEMATOLOGY | AGE | Predictive Value of Tests | Age Factors | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Humans | Heparin - administration & dosage | Hospitals, Pediatric | Infant | Male | Drug Monitoring - methods | Heparin - adverse effects | Fibrinolytic Agents - adverse effects | Drug Dosage Calculations | Female | Retrospective Studies | Thrombosis - blood | Thrombosis - prevention & control | Odds Ratio | Infant, Newborn | Risk Assessment | Risk Factors | Logistic Models | Treatment Outcome | Anticoagulants - adverse effects | Chi-Square Distribution | Blood Coagulation - drug effects | Partial Thromboplastin Time | Blood Coagulation Tests | Fibrinolytic Agents - administration & dosage | Thrombosis - drug therapy | Hemorrhage - chemically induced | Ontario | Thrombosis - diagnosis | Anticoagulants (Medicine) | Glycosaminoglycans | Children's hospitals | Medical societies | Emergency medicine | Anticoagulants | Membranes | Hospitals | Laboratory methods | Oxygenation | Thromboembolism | Risk factors | Guidelines | Index Medicus
Journal Article
Journal Article
ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 11/1993, Volume 119, Issue 9, pp. 874 - 881
Objective: To determine whether an intravenous heparin dosing nomogram based on body weight achieves therapeutic anticoagulation more rapidly than a ''standard... 
ANTICOAGULANTS | MYOCARDIAL-INFARCTION | INITIAL TREATMENT | HEPARIN | INJECTIONS, INTRAVENOUS | PROXIMAL-VEIN THROMBOSIS | MEDICINE, GENERAL & INTERNAL | CONTINUOUS INTRAVENOUS HEPARIN | THERAPY | DEEP VENOUS THROMBOSIS | BODY WEIGHT | PULMONARY-EMBOLISM | DOSE-RESPONSE RELATIONSHIP, DRUG | SUBCUTANEOUS HEPARIN | UNSTABLE ANGINA | DOSAGE
Journal Article
Journal Article
BLOOD COAGULATION & FIBRINOLYSIS, ISSN 0957-5235, 12/2014, Volume 25, Issue 8, pp. 838 - 844
Journal Article